Newsroom

Newsroom

PEI Keynote Interview

Media Coverage

March 1, 2022
Strong partnerships are critical to developing businesses at scale throughout key markets in Europe, say Marco Herbst, Greg Laï, Christian Rochat and Eric Rouzier at Clayton, Dubilier & Rice
Call In Podcast Logo.

Media Coverage

February 24, 2022
Episode 10 of the Call In podcast features a conversation with Julian Francis, President and CEO of Beacon Building Products – the largest publicly traded distributor of roofing materials and complementary building products in the U.S. and Canada...
Vera Whole Health Logo.

Press Release

February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Andrea Peiro

Press Release

February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Hand holding a seedling.

Perspectives

February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics. We believe private equity is well-positioned to drive and scale ESG best practices. The...
Anand Shah, M.D.

Press Release

February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Vera Whole Health and Castlight Health logos

Press Release

January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Jon Selib Headshot

Press Release

December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Belron logo

Press Release

December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Gordon Riske

Press Release

December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...
EDF Climate Corps

Press Release

June 12, 2024
Clayton Dubilier & Rice (“CD&R” or the “Firm”) is pleased to announce its participation in the Environmental Defense Fund (“EDF”) Climate Corps program, which has placed fellows to lead sustainability projects at the Firm and its funds’...
Truist Logo.

Press Release

May 7, 2024
Truist Financial Corporation (NYSE: TFC) today announced that it has completed the previously announced sale of its remaining stake in Truist Insurance Holdings ("TIH"), a subsidiary of Truist and the fifth largest insurance brokerage in the United...
Resideo and Snap One

Press Release

April 15, 2024
Resideo Technologies, Inc. (NYSE: REZI), a leading manufacturer and distributor of technology-driven products and solutions, and Snap One Holdings Corp. (Nasdaq: SNPO), a leading provider of smart-living products, services, and software to...
Elevance-Health-logo-animation

Press Release

April 15, 2024
Elevance Health, Inc. (NYSE: ELV) and Clayton, Dubilier & Rice (CD&R) announced an agreement to form a strategic partnership to accelerate innovation in primary care delivery, enhance the healthcare experience, and improve health outcomes....
Elevance-Health-logo-animation

Press Release

April 15, 2024
Elevance Health, Inc. (NYSE: ELV) and Clayton, Dubilier & Rice (CD&R) announced an agreement to form a strategic partnership to accelerate innovation in primary care delivery, enhance the healthcare experience, and improve health outcomes....
Presidio

Press Release

April 2, 2024
Clayton Dubilier & Rice (“CD&R” or the “Firm”) and BC Partners today announced that they have entered into a definitive agreement under which funds affiliated with CD&R will acquire a majority ownership position in Presidio, a leading...
Jenny Machida

Press Release

March 4, 2024
Clayton, Dubilier & Rice ("CD&R" or the "Firm") today announced the appointment of Jenny Machida as Managing Director of Portfolio Talent, a newly created position to bring additional capability to support our investment teams' focus on...
Leslie Starr

Press Release

February 27, 2024
Clayton, Dubilier & Rice (“CD&R” or the “Firm”) today announced the appointment of Leslie Starr as an Operating Advisor to CD&R funds. Ms. Starr will work with CD&R's consumer team to advise the funds' consumer businesses. Ms. Starr...
Truist Insurance Holdings

Press Release

February 20, 2024
Truist Financial Corporation (NYSE: TFC) today announced that it has reached a definitive agreement to sell its remaining stake in Truist Insurance Holdings ("TIH"), a subsidiary of Truist and the fifth largest insurance brokerage in the United...
Shearers Foods

Press Release

February 13, 2024
Clayton Dubilier & Rice (“CD&R” or the “Firm”) today announced the completion of its acquisition of Shearer’s Foods (“Shearer’s” or the “Company”), a leading contract manufacturer and private label supplier serving the snack industry in the...
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.